US Brand Name(s) for Iobenguane I 131: Azedra
Use in Cancer Treatment
Experts have authorized Iobenguane I 131 to treat the following conditions:
Malignant pheochromocytoma or paraganglioma requires systemic anticancer therapy. Doctors use it in adults and children aged 12 and above; who have had an iobenguane scan and whose illness has had a local progression, or, in other words, spread to other regions of the body; or the ones which even a surgery cannot remove.
Experts are also investigating Iobenguane I 131 for use in the treatment of other cancers.
Detailed scientific definition –Definition from the NCI Drug Dictionary
Iobenguane I 131 injection is used to treat Iobenguane scan positive, advanced or metastatic (cancer that has spread) pheochromocytoma (cancer of the adrenal glands) or paraganglioma in patients who cannot be treated by surgery and also who require systemic cancer treatment.
Doctors give very small doses of radioiodinated iobenguane; however, the radioactivity taken up by the adrenal glands helps find the tumors. An image of the gland on film or on a computer screen can be provided to help with the diagnosis.
A doctor under his direct supervision can only give this medicine, with specialized training in nuclear medicine or radiation oncology.
